Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) were up 6.8% during trading on Monday after UBS Group raised their price target on the stock from $3.20 to $4.50. UBS Group currently has a sell rating on the stock. Aveanna Healthcare traded as high as $5.56 and last traded at $5.55. Approximately 280,641 shares were traded during trading, an increase of 21% from the average daily volume of 232,508 shares. The stock had previously closed at $5.19.
Separately, Truist Financial lowered their target price on shares of Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating for the company in a report on Monday, January 6th.
View Our Latest Report on AVAH
Institutional Investors Weigh In On Aveanna Healthcare
Aveanna Healthcare Stock Performance
The stock has a market capitalization of $1.06 billion, a PE ratio of -16.09 and a beta of 2.25. The business’s 50-day moving average is $4.60 and its two-hundred day moving average is $4.96.
Aveanna Healthcare Company Profile
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Featured Stories
- Five stocks we like better than Aveanna Healthcare
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Must-Own Stocks to Build Wealth This Decade
- What to Know About Investing in Penny Stocks
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.